Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria Last updated: 2023-02-03 03:36
Real-world evidence of Entresto adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction Last updated: 2022-10-18 17:19